Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2234)	9/4/2009 5:47:06 PM
From: Jibacoa	Respond to of 3722

LMNX has not closed its Aug 7 DG, and is trying to find support at the $15 level. Today it was up 3.36 with volume about 1.5x its ADV. bigcharts.marketwatch.com The stock is moving up some AHs. It announced yesterday that it has received clearance from the FDA for a new cystic fibrosis test. LMNX has small LTD, +CF and 4Qs of better revenues and earnings, albeit not on a sequential basis. The EE, although revised down, are still around $0.23 for 2009 and $0.046 for 2010 vs. $0.08 in 2008 The short ratio increased around 18% and is about 9.7x its ADV. In spite of the high PE, it seems that with some good news the stock could get to test the $20 level. <g> bigcharts.marketwatch.com Bernard